Linganisha mbinu

	Wells Score kwa DVT	Kiwango cha Ukali wa Nimonia ya CURB-65	Kiwango cha qSOFA
Nyanja	Tathmini ya Kliniki	Tathmini ya Kliniki	Tathmini ya Kliniki
Familia	Process / pipeline	Process / pipeline	Process / pipeline
Mwaka wa asili	1994	2003	2016
Mwanzilishi	Philip S. Wells	W. Staniford Lim, et al.	Sepsis-3 Taskforce
Aina	Venous thromboembolism risk stratification	Community-acquired pneumonia severity assessment	Rapid sepsis screening
Chanzo asilia	Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546.	Lim, W. S., van der Eerden, M. M., Laing, R., et al. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58(5), 377-382.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
Majina mbadala	Wells DVT Score, DVT Wells	CURB-65, Pneumonia severity	Quick SOFA, qSOFA
Zinazohusiana	3	3	3
Muhtasari	The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients.	CURB-65, derived and validated by Lim et al. in 2003, is a 5-point severity of illness score for community-acquired pneumonia (CAP). It assesses confusion, urea nitrogen, respiratory rate, blood pressure, and age ≥65 years to stratify mortality risk and guide admission and treatment decisions.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.